Used in pharmaceutical research as a potent inhibitor of specific kinases involved in inflammatory and oncogenic signaling pathways. Demonstrates promising activity in preclinical models for treating autoimmune diseases and certain cancers, particularly due to its ability to selectively modulate immune cell function and suppress tumor growth. Its structure allows for enhanced metabolic stability and improved target binding, making it a valuable scaffold in the development of orally available therapeutics. Currently investigated for optimization in drug discovery programs focusing on precision medicine.